|
Market Closed -
Nasdaq
04:00:00 2026-10-02 pm EDT
|
5-day change | 1st Jan Change | ||
| 10.50 USD | -6.75% |
|
-10.79% | -33.04% |
| Oct. 01 | Monte Rosa Therapeutics Announces Positive Data From GFORCE-1 Phase 1 Study Evaluating MRT-8102 | CI |
| Oct. 01 | Monte Rosa Therapeutics, Inc. - Special Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.75% | -10.79% | -26.98% | -56.63% | -33.04% | +35.66% | +134.90% | -47.68% | - | 896M | |
| +4.16% | +3.04% | +7.28% | +37.96% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.16B | |
| -3.11% | -3.53% | -9.46% | -1.19% | +13.76% | +21.92% | +74.60% | +210.63% | +5,229.41% | 57.39B | |
| +0.89% | -0.63% | -3.05% | +0.18% | +5.17% | +4.28% | +34.51% | -18.64% | +204.74% | 47.64B | |
| +0.36% | +0.81% | -2.01% | +9.19% | +159.44% | +342.39% | +742.40% | +609.62% | - | 44.29B | |
| -0.96% | -4.50% | -4.94% | +24.72% | +14.55% | +24.96% | +35.38% | +6.90% | +221.96% | 42.5B | |
| -0.20% | -0.77% | -1.27% | +20.30% | +17.86% | +4.13% | +105.50% | +0.38% | +1,055.06% | 40.71B | |
| -0.54% | +2.93% | -1.99% | +3.40% | +5.93% | +9.31% | +50.41% | -10.44% | +144.22% | 30.97B | |
| -2.68% | +2.92% | +10.78% | +52.12% | +73.51% | +29.63% | +19.50% | -56.88% | - | 28.53B | |
| +0.05% | -1.64% | -5.81% | -0.66% | +1.79% | -8.14% | -11.37% | -61.97% | - | 24.34B | |
| +2.33% | -5.69% | -12.28% | -0.43% | -36.15% | -29.29% | +356.91% | +305.84% | +663.19% | 24.27B | |
| -2.42% | -0.88% | +3.77% | +20.44% | +11.35% | +11.46% | -7.65% | -18.11% | +99.73% | 20.32B | |
| +0.23% | -3.14% | +1.02% | +7.51% | +6.73% | +12.58% | +149.86% | +206.43% | +1,863.54% | 16.73B | |
| -0.43% | +0.87% | -10.73% | -7.36% | +174.96% | +134.11% | +328.09% | +1,692.64% | +635.44% | 15.16B | |
| +0.25% | +1.01% | -15.95% | -16.99% | - | - | - | - | - | 14.96B | |
| +0.43% | -3.23% | +2.86% | +8.27% | +19.97% | +19.13% | +43.03% | -29.30% | +85.14% | 14.63B | |
| +0.78% | +0.40% | -1.25% | +4.55% | +33.22% | +45.65% | +166.86% | +171.08% | +359.04% | 14.47B | |
| -3.04% | +1.11% | -4.22% | +0.98% | +20.40% | -16.05% | +516.45% | - | - | 14.38B | |
| +1.17% | -0.90% | -1.08% | +25.79% | +45.47% | +63.64% | +51.39% | -30.36% | +246.79% | 13.85B | |
| +0.17% | -9.86% | +18.51% | +27.14% | +29.77% | -16.40% | - | - | - | 13.83B | |
| Average | -0.47% | -1.82% | -2.84% | +7.96% | +34.17% | +38.86% | +160.27% | +172.92% | +900.69% | 27.7B | |
| Weighted average by Cap. | +0.08% | -1.25% | -1.48% | +13.83% | +41.25% | +47.52% | +153.69% | +143.89% | +1,286.12% |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
